Research published in the Journal of Clinical Psychiatry shows that of all 901 patients diagnosed with schizophrenia from July 2009 to June 2010 at a community mental health center, white patients were half as likely (OR = .52) than nonwhites to receive long-acting injectable antipsychotics, irrespective of age, gender or comorbid diagnoses including drug abuse. The authors speculate that prescribers may consider nonwhites to be less adherent to antipsychotic medications.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.